These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38639739)

  • 21. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
    Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
    J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction.
    Meng Q; Lai YC; Kelly NJ; Bueno M; Baust JJ; Bachman TN; Goncharov D; Vanderpool RR; Radder JE; Hu J; Goncharova E; Morris AM; Mora AL; Shapiro SD; Gladwin MT
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):497-505. PubMed ID: 28118022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.
    Farrero M; Blanco I; Batlle M; Santiago E; Cardona M; Vidal B; Castel MA; Sitges M; Barbera JA; Perez-Villa F
    Circ Heart Fail; 2014 Sep; 7(5):791-8. PubMed ID: 25047042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.
    Gorter TM; Obokata M; Reddy YNV; Melenovsky V; Borlaug BA
    Eur Heart J; 2018 Aug; 39(30):2825-2835. PubMed ID: 29947750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.
    Naeije R; Gerges M; Vachiery JL; Caravita S; Gerges C; Lang IM
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction.
    Moles VM; Grafton G
    Cardiol Clin; 2022 Nov; 40(4):533-540. PubMed ID: 36210136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension.
    Ahmed S; Ahmed A; Rådegran G
    Int J Cardiol; 2021 Dec; 345():68-76. PubMed ID: 34710494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary Vascular Resistance During Exercise Predicts Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction.
    Huang W; Oliveira RKF; Lei H; Systrom DM; Waxman AB
    J Card Fail; 2018 Mar; 24(3):169-176. PubMed ID: 29180305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction.
    Olsson KM; Sommer L; Fuge J; Welte T; Hoeper MM
    Respir Res; 2015 Mar; 16(1):34. PubMed ID: 25853979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension.
    Salamon JN; Kelesidis I; Msaouel P; Mazurek JA; Mannem S; Adzic A; Zolty R
    J Card Fail; 2014 Jul; 20(7):467-75. PubMed ID: 24858070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension.
    Singh I; Oliveira RKF; Naeije R; Rahaghi FN; Oldham WM; Systrom DM; Waxman AB
    Chest; 2019 Oct; 156(4):724-732. PubMed ID: 31121149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
    Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disproportionate exercise-induced pulmonary hypertension in relation to cardiac output in heart failure with preserved ejection fraction: a non-invasive echocardiographic study.
    Saito Y; Obokata M; Harada T; Kagami K; Sorimachi H; Yuasa N; Kato T; Wada N; Okumura Y; Ishii H
    Eur J Heart Fail; 2023 Jun; 25(6):792-802. PubMed ID: 36915276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary Hypertension secondary to Left Heart Disease.
    Kabbach G; Mukherjee D
    Curr Vasc Pharmacol; 2018; 16(6):555-560. PubMed ID: 28901848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.
    Fayyaz AU; Edwards WD; Maleszewski JJ; Konik EA; DuBrock HM; Borlaug BA; Frantz RP; Jenkins SM; Redfield MM
    Circulation; 2018 Apr; 137(17):1796-1810. PubMed ID: 29246894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.
    Opitz CF; Hoeper MM; Gibbs JS; Kaemmerer H; Pepke-Zaba J; Coghlan JG; Scelsi L; D'Alto M; Olsson KM; Ulrich S; Scholtz W; Schulz U; Grünig E; Vizza CD; Staehler G; Bruch L; Huscher D; Pittrow D; Rosenkranz S
    J Am Coll Cardiol; 2016 Jul; 68(4):368-78. PubMed ID: 27443433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction: pathophysiology and natural history.
    Segers VF; Brutsaert DL; De Keulenaer GW
    Curr Opin Cardiol; 2012 May; 27(3):273-80. PubMed ID: 22327289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
    Guazzi M; Ghio S; Adir Y
    J Am Coll Cardiol; 2020 Sep; 76(9):1102-1111. PubMed ID: 32854845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial.
    Palevičiūtė E; Čelutkienė J; Šimbelytė T; Gumbienė L; Jurevičienė E; Zakarkaitė D; Čėsna S; Eichstaedt CA; Benjamin N; Grünig E
    Trials; 2023 Apr; 24(1):281. PubMed ID: 37072812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors.
    Ovchinnikov A; Potekhina A; Belyavskiy E; Ageev F
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.